News
$Lipella Pharmaceuticals (LIPO.US)$ Lipella Pharmaceuticals Granted U.S. Patent For "DELIVERY OF AGENTS USING METASTABLE LIPOSOMES (FOR LEAD DRUG HEMORRHAGIC CYSTITIS, CANCER, PAINFUL BLADDER SYNDROME)"
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Rafey Jan : why is this not flying?
Trytosaveabit OP Rafey Jan : Got hit by shorts right away! And not enough buys to push back is what it looks to me so far
Arrayfunction : From strictly a business perspective (I don't understand market behavior like @Trytosaveabit) this is only a patent on a technology which they intend to use in the future.
It's not a patent on an actual drug or something they are going to generate revenue with any time soon, if at all. Their drug candidates may make it through trials, but most don't.
They could also sell off the patent to cut losses and exist, but there is little to no value in owning the patent if other companies aren't making successful drugs that use it.
So with how specific the scope of the patent is, unless it is a truly revolutionary way to deliver cancer medication (which it could be, not an oncologist) competitors would try to change any products enough to fall outside the scope of the patent.